Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Classical hematology 1Breast 1

Conditions

Sarcoma 63Osteosarcoma 16Leiomyosarcoma 16Neoplasm Metastasis 10Pancreatic Neoplasms 9Breast Neoplasms 9Bone Neoplasms 8Rhabdomyosarcoma 6Ovarian Neoplasms 6Neoplasms 6Colorectal Neoplasms 6Small Cell Lung Carcinoma 5Sarcoma, Ewing 5Liposarcoma 5Head and Neck Neoplasms 5Colonic Neoplasms 5Sarcoma, Synovial 4Prostatic Neoplasms 4Melanoma 4Histiocytoma, Malignant Fibrous 4Hemangiosarcoma 4Chondrosarcoma 4Carcinoma, Non-Small-Cell Lung 4Stomach Neoplasms 3Recurrence 3Lymphoma, Non-Hodgkin 3Lung Neoplasms 3Gastrointestinal Stromal Tumors 3Esophageal Neoplasms 3Dermatofibrosarcoma 3

Interventions

Gemcitabine 1Enoxaparin 1Aspirin 1ALT-836 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Venous Thromboembolism × Gemcitabine × Sarcoma × Clear all
NCT01325558 2016-07-15

A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors

Altor BioScience

Phase 1 Completed
30 enrolled
BreastClassical hematologyGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡